DrugPatentWatch Database Preview
Drugs in Development Information for Mianserin
Development status for investigational drug Mianserin: Patents, clinical trial progress, indications
Mianserin is an investigational drug.
There have been 5 clinical trials for Mianserin.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2016.
The most common disease conditions in clinical trials are Depressive Disorder, Major, Depressive Disorder, and Depression. The leading clinical trial sponsors are Hospital Universitari de Bellvitge, Duke University, and Forest Laboratories.
Summary for Mianserin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 3,181 |
| WIPO Patent Applications | 2,006 |
| Japanese Patent Applications | 13 |
| Clinical Trial Progress | Phase 3 (2016-03-01) |
| Vendors | 23 |
Recent Clinical Trials for Mianserin
| Title | Sponsor | Phase |
|---|---|---|
| Treatment of Sleep Disturbances in Trauma-affected Refugees | Danish Center for Sleep Medicine | Phase 4 |
| Treatment of Sleep Disturbances in Trauma-affected Refugees | Mental Health Services in the Capital Region, Denmark | Phase 4 |
| Pharmacovigilance in Gerontopsychiatric Patients | Hannover Medical School | Phase 3 |
Clinical Trial Summary for Mianserin
Top disease conditions for Mianserin
Top clinical trial sponsors for Mianserin
US Patents for Mianserin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
